“Two major, interconnected problems afflict organ transplantation today: the widening gap between the demand for organs and their supply and the illegal, exploitative organ trade. [..] Organ trade profits from this gap by preying upon both patients waiting for and willing to buy an organ and potential donors living in poverty and willing to sell one. In particular, the principle of financial neutrality has been questioned. This principle states that a donor or their related family should not lose, but also not gain, monetarily as a result of donation, implying that the organ does not become a commodity and money … Read More
All posts in Health Policy
“Many patients and their families understandably wish to delay death. Others find the experience torturous: the ever-mounting costs, the endless cycle of interventions, the literal and figurative sterility of the hospital environment. Some doctors and nurses secretly wonder whether these practices are in the best interests of their patients. I am one of them. Some years ago, I began to advocate a revival of the medieval practice of ars moriendi, or the art of dying — a more accepting, less fearful, more community-based approach to the end of life. I believe that in many cases, it is wise to forgo … Read More
“The chief risk of developing general AI [artificial intelligence] too rapidly is misalignment—when an AI system’s objectives diverge from human values. The AI research community has identified several considerations that increase misalignment risk, illustrated in the Box using neurology-specific examples. These illustrative cases might seem straightforward to detect and correct. However, if we succeed in developing a general AI that far exceeds human intelligence, the stakes become higher and intervention more difficult. In neurology, superintelligent AI could become essential for tasks like diagnosing conditions, personalizing treatments, managing hospitals, and making critical decisions. If a superintelligent AI conceals misalignment, however, it … Read More
“To help put alcohol taxes in perspective: the federal tax on a pack of cigarettes is now approximately $1, and states and localities can layer on additional taxes. Customers in New York City, for instance, pay a $5.35 state tax and an additional $1.50 city tax for a combined total of $6.85 per pack — far beyond the average state tax of $1.93 nationally. Meanwhile, since the mid-20th century, relative alcohol tax rates have receded by roughly three quarters and have fallen well below those in other high-income countries, in contradistinction to trends in taxation of nicotine products. It has … Read More
“[Introduction] Despite spending more than any country in the world on health care, life expectancy in the US is comparably worse than that of most other high-income countries and declining both in absolute value and relative rank. However, life expectancy across US states varies just as markedly as it does across high-income countries, from 81.8 years in Hawaiʻi to 74.7 years in Mississippi in 2019—a divergence that has been increasing over time. US states vary considerably on policy decisions related to the spending, regulation, and provision of health care; reproductive health; tax policy; social welfare programs; and in relation to … Read More
The Trump administration is manipulating government-sponsored research to get the answers it wants. “Since its first days, the new Trump administration has clearly shown where it thinks scientific attention should not be focused: It has attempted to censor federal scientific data, cut billions in government spending on research, and compromised care for some of the world’s most at-risk populations. Now, as the nation’s leaders have begun to encourage inquiry into specific areas, they are signaling that they’re willing to not just slash and burn research that challenges their political ideology but to replace it with shoddy studies designed to support … Read More
A plan was set in motion with no idea of how to stop it. “While federal public-health officials made recommendations regarding schools, the actual closures were carried out at the state and local levels, in response to misplaced public fears and aggressive campaigning by teachers’ unions. Randi Weingarten, the high-profile head of the American Federation of Teachers, said in a February 8, 2021, New York Times article that she hoped things would be “as normal as possible” by the following fall. Class-action lawsuits in multiple states had been filed on behalf of children with special needs on the claim that … Read More
“The results Lilly announced came from a clinical trial involving 559 people with Type 2 diabetes who took the new pill or a placebo for 40 weeks. In patients who took orforglipron, blood sugar levels fell by 1.3 to 1.6 percent, about the same amount in that time period experienced by patients taking Ozempic and Mounjaro in unrelated trials. For 65 percent of people taking the new pill, blood sugar levels dropped into the normal range. Patients on the new pill also lost weight — up to 16 pounds without reaching a plateau at the study’s end. Their weight loss … Read More
“Health care spending as a proportion of total national spending has been flat, at approximately 17%, since the late 2000s, meaning that health care cost growth hasn’t exceeded growth in the gross domestic product, on average. Per-beneficiary Medicare spending grew at an average rate of 6.6% per year between 1987 and 2005, but by 2.2% per year between 2013 and 2019. [..] low growth has persisted well beyond the Great Recession for all types of insurance. Putting aside the spike in health care spending that occurred during the Covid-19 pandemic, growth in per-capita national health expenditures has been low by … Read More
“Opioid overdose continues to be the leading cause of death due to injury in the US. Recent data from the Drug Abuse Warning Network estimated 882 000 emergency department (ED) opioid-related visits in 2023, a rate of 263 per 100 000 visits, with the highest rates among Black individuals (425 per 100 000). Access to treatment with medications for opioid use disorder, specifically buprenorphine, continues to be challenging for patients in active addiction, and these disparities by race are widening. [..] In many states, rural patients with opioid use disorder have worse outcomes than urban patients. Rural hospitals are also less likely to … Read More